In-Home COVID-19 Testing for Children With Medical Complexity: Feasibility and Association With School Attendance and Safety Perceptions.
- Resource Type
- Article
- Authors
- Coller, Ryan J., ; Kelly, Michelle M.; Howell, Kristina Devi; Warner, Gemma; Butteris, Sabrina M.; Ehlenbach, Mary L.; Werner, Nicole; Katz, Barbara; McBride, Joseph A.; Kieren, Madeline; Koval, Shawn; DeMuri, Gregory P.
- Source
- American Journal of Public Health; 2022 Suppl 9, Vol. 112, pS878-S882, 5p
- Subject
- School health services
Human services programs
Parents
Public health surveillance
Home care services
Chronic diseases in children
Guardian & ward
COVID-19 testing
Patient self-monitoring
Patient safety
- Language
- ISSN
- 00900036
The REstarting Safe Education and Testing program for children with medical complexity was implemented in May 2021 at the University of Wisconsin to evaluate the feasibility of in-home rapid antigen COVID-19 testing among neurocognitively affected children. Parents or guardians administered BinaxNOW rapid antigen self-tests twice weekly for three months and changed to symptom and exposure testing or continued surveillance. In-home testing was feasible: nearly all (92.5%) expected tests were conducted. Symptomatic testing identified seven of nine COVID-19 cases. School safety perceptions were higher among those opting for symptom testing. Clinical Trials.gov identifier: NCT04895085. (Am J Public Health. 2022;112(S9):S878–S882. https://doi.org/10.2105/AJPH.2022.306971) [ABSTRACT FROM AUTHOR]